Development of Novel Stability Indicating Methods Using Liquid Chromatography
Autor Mukesh Maithani, Parveen Bansalen Limba Engleză Paperback – 16 aug 2020
This book presents a simple methodology for developing stability-indicating methods and offers a ‘how-to guide’ to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 646.44 lei 38-44 zile | |
| Springer Nature Singapore – 16 aug 2020 | 646.44 lei 38-44 zile | |
| Hardback (1) | 656.66 lei 38-44 zile | |
| Springer Nature Singapore – 16 aug 2019 | 656.66 lei 38-44 zile |
Preț: 646.44 lei
Preț vechi: 680.46 lei
-5% Nou
Puncte Express: 970
Preț estimativ în valută:
123.71€ • 130.83$ • 103.19£
123.71€ • 130.83$ • 103.19£
Carte tipărită la comandă
Livrare economică 25-31 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811387258
ISBN-10: 9811387257
Pagini: 101
Ilustrații: XXII, 101 p. 36 illus., 7 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2019
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
ISBN-10: 9811387257
Pagini: 101
Ilustrații: XXII, 101 p. 36 illus., 7 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2019
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
Cuprins
Chapter 1. Introduction.- Chapter 2. Research Envisaged.- Chapter 3. Drug(s) Profile.- Chapter 4. Materials and Methods.- Chapter 5. Results and Discussion.- Chapter 6. Summary and Conclusion.-
Notă biografică
Dr. Mukesh Maithani, M.Pharma., Ph.D. in pharmaceutical sciences is a Scientist working with the Multidisciplinary Research Unit (ICMR), University Center of Excellence in Research, Baba Farid University of Health Sciences, Faridkot, India. He received the Young Scientist Award from the All India Medicos Society during its 26th National Medical Congress in 2011 and has more than 12 years experience as a Research Scientist at Zydus Research Centre, Ahmadabad; and as a Senior Research Scientist at the Analytical Development Laboratory, Alembic Research Centre, Vadodara.
Dr. Maithani has made major contributions to pharmaceutical analysis, herbal formulations, and the standardization of drugs. His expertise includes drug discovery, novel analytical techniques, herbal excipients and drugs, targeted drug delivery etc. He has published more than thirty papers in national and international journals and conference proceedings, and is a co-author of seventeen books/book chapters. In addition, Dr. Maithani serves as a reviewer and advisory board member for several international and national journals.
Dr. Parveen Bansal, Ph.D. (Biochemistry), FRSM, FICA (USA), Joint Director, Baba Farid University of Health Sciences, has more than 23 years experience in various positions including Assistant Director/Founder Head of the National Institute of Ayurvedic Pharmaceutical Research. He represented India as a member of the 23rd Indian Scientific Expedition to Antarctica. He holds three Young Scientist Awards, a Gold Medal from Gujarat Ayurveda University, Jamnagar, an Honorary Fellowship from the International Council of Ayurveda (USA), and a WHO In-country Fellowship from the World Health Organization. He has been nominated as a Member of the Screening Committee for the Cancer Consortium R&D Program, Department of Biotechnology, GOI, has published more than 170 research papers, 17 books and 46 book chapters, and serves as a reviewer or editorial board member for 35 high-impact international journals.
Dr. Maithani has made major contributions to pharmaceutical analysis, herbal formulations, and the standardization of drugs. His expertise includes drug discovery, novel analytical techniques, herbal excipients and drugs, targeted drug delivery etc. He has published more than thirty papers in national and international journals and conference proceedings, and is a co-author of seventeen books/book chapters. In addition, Dr. Maithani serves as a reviewer and advisory board member for several international and national journals.
Dr. Parveen Bansal, Ph.D. (Biochemistry), FRSM, FICA (USA), Joint Director, Baba Farid University of Health Sciences, has more than 23 years experience in various positions including Assistant Director/Founder Head of the National Institute of Ayurvedic Pharmaceutical Research. He represented India as a member of the 23rd Indian Scientific Expedition to Antarctica. He holds three Young Scientist Awards, a Gold Medal from Gujarat Ayurveda University, Jamnagar, an Honorary Fellowship from the International Council of Ayurveda (USA), and a WHO In-country Fellowship from the World Health Organization. He has been nominated as a Member of the Screening Committee for the Cancer Consortium R&D Program, Department of Biotechnology, GOI, has published more than 170 research papers, 17 books and 46 book chapters, and serves as a reviewer or editorial board member for 35 high-impact international journals.
Textul de pe ultima copertă
Reversed-phase high-performance liquid chromatography (RP-HPLC) has become the most widely used method for pharmaceutical analysis, as it ensures accuracy, specificity and reproducibility for the quantification of drugs, while avoiding interference from any of the excipients that are normally present in pharmaceutical dosage forms.
This book presents a simple methodology for developing stability-indicating methods and offers a ‘how-to guide’ to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.
This book presents a simple methodology for developing stability-indicating methods and offers a ‘how-to guide’ to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.
Caracteristici
Provides simple methodology for Stability indicating methods for drug substance and drug product Describes in detail Reversed-phase high performance liquid chromatography (RP-HPLC) Identifies key factors that may affect the quality of a drug substance and drug product and may cause it to change under the influence of various environmental factors